Navigation Links
GNS Healthcare Collaborates with NCI in New Approach to Lung Cancer; Supercomputer Analysis to Aid in Matching Targeted Drugs to Patients
Date:8/13/2011

CAMBRIDGE, Mass., July 12, 2011 /PRNewswire/ -- GNS Healthcare, Inc. (GNS) is collaborating with the National Cancer Institute (NCI) to accelerate lung cancer research with a supercomputing platform that can rapidly uncover cause-and-effect mechanisms hidden in huge data sets assembled from imaging, genetics, pathology, and other areas. The results could help predict which patients will respond to a given treatment.

GNS will analyze NCI data from the laboratory of Terry van Dyke, Ph.D., Director of the Center for Advanced Preclinical Research (CAPR) at NCI. These data were generated from genetically modified mouse models of non-small cell lung cancer (NSCLC).

This collaboration will utilize GNS's supercomputer-driven REFS(TM) platform to build computer models of NSCLC in a hypothesis-free, unbiased manner that will be simulated to identify key molecular mechanisms of NSCLC.  The goal is to identify biomarkers and biological mechanisms that will lead to better matching of drugs to patients and new effective drugs in NSCLC.

"GNS is excited to be deploying our supercomputer-driven REFS(TM) platform to enable the maximal extraction of actionable knowledge from the rich lung cancer datasets generated by the NCI," said GNS Executive Vice President and Co-Founder Dr. Iya Khalil. "Combined with the expertise of our NCI colleagues in lung cancer biology and in designing powerful experiments to uncover its key mechanisms, we are creating the opportunity to provide better outcomes for lung cancer patients."

The data utilized in the collaboration will include data from the experimental assessment of transcriptomic and MRI data relating to NSCLC induction, regression and combination drug treatments.  Starting from this data, GNS will utilize the REFS(TM) platform to reverse-engineer network models from the data that connect drug doses to transcriptional and imaging measurement networks to endpoi
'/>"/>

SOURCE GNS Healthcare, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. GE Healthcare studies report results of [18F]Flutemetamol research
2. GNS Healthcare Collaborates with NCI in New Approach to Lung Cancer; Supercomputer Analysis to Aid in Matching Targeted Drugs to Patients
3. New Healthcare Franchise Opportunity Focuses on Treating Exploding Senior Population
4. Corning, GE Healthcare to receive Technical Achievement Award from Ceramic Society
5. Lexicon to Present Clinical Data for Diabetes Drug Candidate, LX4211, at Two Major Healthcare Conferences
6. Inventor honored for tech improving access to clean water, healthcare, and business development in India
7. The Full Yield, Inc. Launches Breakthrough Collaboration to Put Food Back at the Heart of Healthcare
8. TGen-Scottsdale Healthcare researchers make breakthrough in lung cancer
9. GE Healthcare to evaluate and develop novel imaging technology
10. Scott & White Healthcare researcher finds success with new anti-cancer drug
11. Scott & White Healthcare researcher finds success with new anti-cancer drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2015)... , July 13, 2015 Synaptics ... of human interface solutions, today announced sampling of ... and display driver integration (TDDI) product targeting smartphones ... first to combine Synaptics , best-in-class touch ... display driver technology developed in the company,s Japan ...
(Date:7/9/2015)... SAN JOSE, Calif. , July 9, ... ), the leading developer of human interface ... authentication technology, the industry,s first fully hardware ... innovative Match-in-Sensor secure authentication technology is literally ... pattern storage and biometric matching within the ...
(Date:7/7/2015)... -- Research and Markets ( ... "Capacitive Fingerprint Sensors Patent Landscape" report ... fingerprint sensing technology is the most reliable and ... developed. This patent landscape focuses on fingerprint sensors ... of capacitive fingerprint sensors is closely linked to ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2
... of years, plant taxonomists have worked to understand ... only reliable source of information about these relationships ... measured, counted, categorized, and described visually. And paramount ... shape and arrangement. In the papilionoid ...
... 4, 2013Sanford-Burnham Medical Research Institute (Sanford-Burnham) and 60 Pharmaceuticals, ... furin, a human proteinase, as a drug target for ... common infectious diseases in the tropics and subtropics. 60 ... diseases, agreed to provide funding to Sanford-Burnham for the ...
... to stimulate an immune system assault fail because the killer T ... inviting target, scientists at The University of Texas MD Anderson Cancer ... used in many cancer vaccines to boost immune attack betrays the ... site, which then summon more T cells to help with the ...
Cached Biology News:Don't be fooled: Flowers mislead traditional taxonomy 2Sanford-Burnham and 60° Pharmaceuticals to pursue promising target for the treatment of dengue fever 2Cancer vaccines self-sabotage, channel immune attack to injection site 2Cancer vaccines self-sabotage, channel immune attack to injection site 3Cancer vaccines self-sabotage, channel immune attack to injection site 4
(Date:7/29/2015)... , July 29, 2015  Therapath Neuropathology ( ... increased partnerships with VA and Military Medical centers ... Fiber Density (ENFD) and Sweat Gland Nerve Fiber ... neuropathy ( https://therapath.com/skin ). Demonstration ... Density (ENFD) on punch skin biopsy is a ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - Aeterna Zentaris ... announced it has selected an optimized Erk inhibitor ... in the development of a new class of ... pathway represents a prime target for therapeutic intervention ... activities and survival benefits for B-Raf and Mek ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... cell culture products, announces the availability of BI’s line of human mesenchymal stem ... these stem cell differentiation media offer a complete system for multipotency evaluation of ...
(Date:7/28/2015)... ... ... new Xsample 530 sample changer for vials can be used with Anton Paar ... less than 12,000 mPas (internal air) up to 36,000 (external air) – and can process ... about Xsample 530 is its removable magazine, which is easily lifted off its hub and ...
Breaking Biology Technology:Neuropathology services for VA and Military health systems 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 2Rainbow Scientific, Inc. Announces Availability of Human Mesenchymal Stem Cell Differentiation Media 3New Moves in Automatic Sample Handling: Introducing Xsample 530 2
... Charter Business , a division of ... develop its partnership with Berbee Information Networks ... Pharmacy Cooperative (IPC) to Berbees data center in ... T1 lines between multiple Telco vendors, Charter hands off ...
... Metavante Corporation and First Data Corporation ... agreement that provides for the purchase of substantially all ... Metavante for approximately $610 million in cash. As the ... approximately $389 million and NYCE will become a Metavante ...
... exposures to agricultural and lawn care pesticides may cause ... noticed, according to a study conducted by ... being published in the May 2004 issue of ... Institute of Environmental Health Sciences, National Institutes of Health. ...
Cached Biology Technology:Charter and Berbee connect Pharmacy Cooperative 2Metavante and First Data to buy PIN-debit company NYCE 2Infertility linked to lawn chemicals by Marshfield Clinic researcher 2
... Zero Background/Kan Cloning Kit includes ... resistance for selection in E. ... positive selection to eliminate high ... of the reagents you need ...
Protein Phosphorylation...
... and 2.0 mL samples for freezing point determinations. Includes built-in printer, keypad, ... with optional scanner. RS-232 port. Microprocessor-controlled autocalibration. Two-step Calibration. ... ... ...
X-Gal...
Biology Products: